The current prevalence of irritable bowel syndrome in Asia
- PMID: 21103420
- PMCID: PMC2978391
- DOI: 10.5056/jnm.2010.16.4.389
The current prevalence of irritable bowel syndrome in Asia
Abstract
Irritable bowel syndrome (IBS) has been one of the commonly presented gastrointestinal disorders. It is of interest how commonly it presents in the society. Western studies indicated that most population-based IBS prevalences range 10%-15%. It is believed that IBS is prevalent in both East and West countries without a significant prevalence difference. Most recently, the Asia IBS prevalence has a higher trend in the affluent cities compared to South Asia. Since many Asia IBS prevalence studies have been published in the recent decade, we could compare the IBS prevalence data divided by various criteria in looking whether they were also comparable to this of West community. Summarized together, most Asia community IBS prevalences based on various criteria are usually within the range 1%-10% and are apparently lower than these of selected populations. Within the same population, the prevalence orders are first higher based on Manning criteria, then followed by Rome I criteria and finally reported in Rome II criteria. Overall, the median value of Asia IBS prevalences defined by various criteria ranges 6.5%-10.1%. With regard to gender difference, female predominance is usually found but not uniquely existed. For the IBS subtypes, the proportions of diarrhea predominant-IBS distribute widely from 0.8% to 74.0%, while constipation predominant-IBS proportion ranges 12%-77%. In conclusions, current Asia IBS prevalence is at least equal to the Western countries. Female predominant prevalence in Asia is common but not uniquely existed, while the proportions of IBS subtypes are too variable to find a rule.
Keywords: Asia; Gastrointestinal motility; Irritable bowel syndrome; Prevalence.
Conflict of interest statement
Conflicts of interest: None.
Similar articles
-
Prevalence of irritable bowel syndrome: a community based study from northern India.J Neurogastroenterol Motil. 2011 Jan;17(1):82-7. doi: 10.5056/jnm.2011.17.1.82. Epub 2011 Jan 26. J Neurogastroenterol Motil. 2011. PMID: 21369496 Free PMC article.
-
Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia.J Gastroenterol Hepatol. 2007 Jan;22(1):4-12. doi: 10.1111/j.1440-1746.2006.04672.x. J Gastroenterol Hepatol. 2007. PMID: 17201873 Review.
-
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.Scand J Gastroenterol. 2001 Nov;36(11):1155-61. doi: 10.1080/00365520152584770. Scand J Gastroenterol. 2001. PMID: 11686214 Clinical Trial.
-
The clinical significances of irritable bowel syndrome in Taiwan.J Gastroenterol Hepatol. 2011 Apr;26 Suppl 3:102-5. doi: 10.1111/j.1440-1746.2011.06646.x. J Gastroenterol Hepatol. 2011. PMID: 21443720 Review.
-
Prevalence of irritable bowel syndrome in Hong Kong.J Gastroenterol Hepatol. 2002 Nov;17(11):1180-6. doi: 10.1046/j.1440-1746.2002.02871.x. J Gastroenterol Hepatol. 2002. PMID: 12453277
Cited by
-
Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.Nutrients. 2019 Nov 27;11(12):2887. doi: 10.3390/nu11122887. Nutrients. 2019. PMID: 31783597 Free PMC article. Clinical Trial.
-
Blastocystis ST-1 is associated with Irritable Bowel Syndrome-diarrhoea (IBS-D) in Indonesian adolescences.Parasite Epidemiol Control. 2019 May 31;6:e00112. doi: 10.1016/j.parepi.2019.e00112. eCollection 2019 Aug. Parasite Epidemiol Control. 2019. PMID: 31528737 Free PMC article.
-
The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical Dilemma.Nutrients. 2015 Dec 10;7(12):10417-26. doi: 10.3390/nu7125541. Nutrients. 2015. PMID: 26690475 Free PMC article. Review.
-
Cultural Factors Influencing Functional Gastrointestinal Disorders in the East.J Neurogastroenterol Motil. 2018 Oct 1;24(4):536-543. doi: 10.5056/jnm18064. J Neurogastroenterol Motil. 2018. PMID: 30153722 Free PMC article. Review.
-
Epidemiology of functional gastrointestinal disorders using ROME III adult questionnaire, a population based cross sectional study in Karachi-Pakistan.PLoS One. 2022 Jun 13;17(6):e0268403. doi: 10.1371/journal.pone.0268403. eCollection 2022. PLoS One. 2022. PMID: 35696397 Free PMC article.
References
-
- Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–1390. - PubMed
-
- Kellow JE, Azpiroz F, Delvaux M, et al. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology. 2006;130:1412–1420. - PubMed
-
- Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol. 2007;102:2767–2776. - PubMed
-
- Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008;20(suppl 1):121–129. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources